Loading...
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call indicates strong financial performance with an 8% increase in adjusted EBITDA and a 100 basis points margin expansion. The company is actively reducing exposure to China, which is a proactive risk management strategy. Despite some market challenges, the company's guidance remains optimistic with continued growth in institutional markets. The significant share repurchase and dividend increases further support a positive outlook. However, uncertainties around tariffs and economic factors are noted, but overall sentiment leans positive given the strategic actions and financial health.
Fourth Quarter Sales $371 million, up 4% year-over-year due to mid-single digit core sales growth in non-residential end markets, partially offset by softness in residential and commercial segments.
Adjusted EBITDA $91 million, up 8% year-over-year, with adjusted EBITDA margin expanding 100 basis points to 24.6%, driven by productivity initiatives and Elkay-related synergies.
Full Year EBITDA $390 million, up 15% year-over-year, reflecting a $50 million increase in EBITDA growth from $36 million in sales growth.
Full Year Margins 24.9%, up 270 basis points year-over-year, attributed to strong execution on growth initiatives and productivity improvements.
Free Cash Flow (Q4) $55 million, contributing to a full-year total of $272 million, indicating strong cash generation capabilities.
Share Repurchases (Q4) $20 million for 533,000 shares, totaling $150 million for the full year at an average price of just under $32.
Dividends (Year-to-Date) $57 million, reflecting a commitment to returning capital to shareholders.
Net Debt Leverage 0.8x, indicating a strong balance sheet position and financial flexibility.
Sustainability Initiatives: In 2024, Zurn Elkay advanced its sustainability strategy, focusing on optimizing products to reduce water usage and enhancing filters to remove contaminants.
Product Donations: The company made product donations in communities facing high levels of lead in drinking water, including Syracuse, New York.
Core Sales Growth: The company achieved 4% core sales growth in Q4 2024, with expectations for similar growth in 2025.
Market Positioning: Zurn Elkay is focusing on low single-digit growth in institutional and waterworks end markets, while navigating a low single-digit decline in commercial markets.
Adjusted EBITDA Growth: Adjusted EBITDA grew 15% to $390 million for the total year, with margins improving to 24.9%.
Free Cash Flow: Free cash flow for the year was $272 million, with $55 million generated in Q4.
Continuous Improvement: The company documented 3,749 unique continuous improvement submissions, resulting in estimated savings of $5.9 million.
Share Repurchase Program: Zurn Elkay repurchased $150 million worth of shares in 2024, with $20 million in Q4.
Tariff Strategy: The company is reducing its exposure to materials from China to less than 10% by the end of 2026.
Tariff Environment: The company is actively monitoring the tariff environment, which is considered an uncertainty impacting 2025. Although they managed the initial tariffs well, they are aware of the potential challenges that may arise from ongoing tariff dynamics.
Exposure to China: Zurn Elkay has implemented a multi-year strategy to reduce exposure to materials from China, aiming to have less than 10% exposure by the end of 2026. This reduction is a proactive measure to mitigate risks associated with reliance on Chinese materials.
Market Conditions: The company anticipates a low single-digit decline in commercial end markets, which may impact overall sales growth. This decline is expected to be partially offset by growth in institutional and waterworks end markets, indicating a mixed market outlook.
Supply Chain Challenges: The company has faced challenges in the supply chain, particularly related to shipping days, which may affect first-quarter performance due to one less shipping day compared to the prior year.
Economic Factors: The overall market is described as flattish, indicating potential economic challenges that could impact growth and profitability.
Core Growth Initiatives: The company anticipates capturing approximately a point-of-price realization during the year and expects strategic growth initiatives to generate positive core growth over the prior year.
Sustainability Strategy: Zurn Elkay is advancing its sustainability strategy, focusing on continuous improvement and solving complex water issues, while also engaging in community support through volunteerism and product donations.
Continuous Improvement Culture: The company has institutionalized a culture of continuous improvement, documented 3,749 unique submissions in the past year, and aims to reach 5,000 submissions in 2025.
Strategic Focus Areas: The company is focusing on four strategic breakthroughs for 2025, which will guide resource allocation and decision-making.
2025 Core Sales Growth: The company expects core sales growth similar to 2024, with low single-digit growth in institutional and waterworks end markets.
2025 Adjusted EBITDA: Projected adjusted EBITDA for 2025 is between $405 million and $420 million.
2025 Free Cash Flow: Expected free cash flow for 2025 is approximately $290 million.
2025 Adjusted EBITDA Margin: For Q1 2025, the adjusted EBITDA margin is projected to be in the range of 24.5% to 25%.
Long-term Growth Rate: The company has a longer-term core sales CAGR of 6% over the past 10 years.
Dividends Paid: $57 million was deployed to dividends for the year.
Share Repurchase: $150 million was used for share repurchases throughout the year, with $20 million in the fourth quarter.
The earnings call reveals strong financial performance with EBITDA growth, increased free cash flow, and expanded margins. The company's strategic initiatives, such as reducing tariff impacts and launching new products, are well-received. Share repurchases and dividend hikes show confidence in financial health. Despite some management vagueness, the overall sentiment is positive, supported by raised guidance and strong product uptake.
The earnings call summary indicates positive sentiment overall. Basic financial performance shows growth across all product categories, with significant unit volume growth and sustainable share gains. The product development update is optimistic, with double-digit growth in new filtration offerings. Market strategy remains robust, with M&A readiness and strong end-market outlooks. Financial health is stable, with balanced inventory and positive margin expectations. The shareholder return plan is not explicitly detailed, but the overall narrative suggests confidence in continued growth, leading to a positive stock price movement prediction.
The earnings call indicates strong financial performance with an 8% increase in adjusted EBITDA and a 100 basis points margin expansion. The company is actively reducing exposure to China, which is a proactive risk management strategy. Despite some market challenges, the company's guidance remains optimistic with continued growth in institutional markets. The significant share repurchase and dividend increases further support a positive outlook. However, uncertainties around tariffs and economic factors are noted, but overall sentiment leans positive given the strategic actions and financial health.
The earnings call reveals strong financial performance with a 4% organic sales growth and significant margin expansion. The company is committed to shareholder returns, evidenced by a 12.5% dividend increase and substantial share repurchases. While economic factors and market uncertainty are acknowledged, the Q&A highlights sustained demand and growth, particularly in drinking water products. The management's confidence in future pricing and supply chain savings supports positive sentiment. Despite some vague responses, the overall outlook is optimistic, suggesting a likely stock price increase of 2% to 8% over the next two weeks.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.